US · POM
POMDOCTOR Ltd
- Sector
- Healthcare · Medical - Pharmaceuticals
- Headquarters
- Guangzhou 510000
- Website
- 7lk.com
Price · as of 2024-12-31
$0.38
Market cap 25.85M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
AI valuation
Our deep-learning model estimates POMDOCTOR Ltd's (POM) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $0.38
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| POM | POMDOCTOR Ltd | $0.38 | 25.85M | — | — | — | — | — | — | — | — | — | — | 13.92% | -7.53% | -41.85% | 1.70% | 1.46% | -66.41% | -0.19 | -1.99 | 0.21 | 0.13 | -17.86 | -163.00% | 1237.00% | -6478.00% | — | -0.09 | 0.91% | — | 0.00% | — | — | — | — | — |
| AIRS | AirSculpt Technologies, I… | $1.58 | 98.65M | +1,797% | -14% | — | — | -23.74 | 2.47 | 1.09 | 29.06 | -30.65 | -4.45 | 60.42% | -1.01% | -4.57% | -10.11% | -1.04% | -3.99% | 1.32 | -0.29 | 0.60 | 0.39 | 9.61 | 7744.00% | -795.00% | -11893.00% | -1.36% | 0.40 | -1.52% | 0.13% | -3.10% | 0.59% | -161.16 | -110.15 | 1.62 | 1.48 |
| AQST | Aquestive Therapeutics, I… | $4.00 | 397.23M | +466% | -73% | — | — | -5.21 | -3.82 | 3.99 | -7.37 | -1.78 | -3.82 | 68.95% | -53.46% | -76.68% | 52.97% | 32.25% | -55.57% | -0.63 | -1.83 | 4.68 | 4.18 | 1.26 | 29231.00% | 1380.00% | 38702.00% | -15.63% | -1.90 | 37.66% | 0.00% | 0.00% | 18.71% | -6.38 | -5.46 | 3.41 | -3.77 |
| AVXL | Anavex Life Sciences Corp… | $4.43 | 410.54M | — | — | — | — | -8.09 | 3.96 | — | -5.88 | -210.39 | 3.96 | 0.00% | — | — | -43.11% | 523.72% | -38.75% | 0.00 | — | 11.60 | 11.56 | 2.21 | 385.00% | — | 2672.00% | -10.40% | -4.36 | 397.76% | 0.00% | 0.00% | 0.00% | -5.30 | -6.98 | — | 19.47 |
| CTMX | CytomX Therapeutics, Inc. | $5.37 | 909.87M | +2,414% | -87% | -65% | +202% | 1.76 | -123.14 | 0.41 | -1.31 | — | -28.25 | 100.00% | 18.10% | 23.08% | -133.06% | -16.56% | 19.77% | -20.58 | — | 1.25 | 1.21 | -1.07 | -503506.00% | 3645.00% | 5216.00% | -154.12% | -1.01 | 57.76% | 0.00% | 0.00% | 45.36% | -1.40 | 0.41 | -0.25 | -5.71 |
| ERAS | Erasca, Inc. | $13.66 | 4.23B | — | — | — | — | -2.21 | 0.84 | — | -0.73 | — | 0.84 | 0.00% | — | — | -43.68% | -151.38% | -36.01% | 0.12 | — | 9.84 | 9.58 | 0.10 | -1687.00% | — | 2814.00% | -36.89% | -3.49 | -111.24% | 0.00% | 0.00% | 0.00% | -0.62 | -0.84 | — | 0.06 |
| FLGT | Fulgent Genetics, Inc. | $15.33 | 473.89M | +1,814% | -46% | +66% | — | -7.09 | 0.39 | 1.35 | -2.21 | -17.85 | 0.43 | 40.56% | -19.10% | -18.75% | -5.49% | -6.54% | -5.07% | 0.00 | -821.75 | 6.48 | 4.95 | 1.08 | 3972.00% | 1383.00% | 54509.00% | -28.42% | -1.20 | -14.97% | 0.00% | 0.00% | 3.19% | -1.65 | -0.82 | 0.31 | 3.63 |
| INNV | InnovAge Holding Corp. | $8.96 | 1.22B | +275% | -51% | -93% | — | -14.52 | 2.18 | 0.60 | 151.10 | -38.72 | 5.76 | 68.50% | -3.49% | -3.55% | -14.02% | -11.68% | -6.22% | 0.43 | -6.45 | 1.07 | 0.88 | 10.98 | 3750.00% | 1176.00% | -15937.00% | 5.18% | 0.20 | 10.44% | 0.00% | 0.00% | 5.16% | -17.08 | 19.11 | 0.60 | 2.17 |
| OFIX | Orthofix Medical Inc. | $13.53 | 535.78M | +193% | -60% | — | — | — | 1.18 | 0.65 | -30.45 | — | 2.92 | 67.09% | -8.33% | -11.21% | 0.00% | -11.44% | 0.00% | 0.51 | -3.92 | 2.45 | 1.28 | -6.59 | -3091.00% | 285.00% | -8592.00% | -0.24% | 0.20 | -0.21% | 0.00% | — | 0.00% | -9.94 | -532.03 | 0.83 | 1.24 |
| PACB | Pacific Biosciences of Ca… | $1.68 | 507.2M | +1,311% | -61% | — | — | -0.89 | 90.85 | 3.04 | -28.24 | -1.27 | -1.48 | 31.67% | -348.46% | -341.47% | -213.45% | -87.50% | -53.45% | 141.98 | -80.18 | 6.89 | 5.79 | -14.03 | 7009.00% | 389.00% | -4633.00% | -23.44% | -2.04 | -17.88% | 0.00% | 0.00% | 28.22% | -1.73 | -8.48 | 6.04 | -1.28 |
| SIBN | SI-BONE, Inc. | $15.52 | 673.43M | +222% | +44% | -88% | — | -36.13 | 3.85 | 3.40 | -49.18 | — | 3.85 | 79.57% | -11.11% | -9.41% | -10.97% | -52.40% | -8.06% | 0.01 | -4.23 | 8.55 | 7.03 | 3.77 | -4133.00% | 2019.00% | -6035.00% | -1.33% | -0.03 | -21.33% | 0.00% | 0.00% | 6.39% | -24.02 | -59.01 | 2.67 | 5.57 |
About POMDOCTOR Ltd
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
- CEO
- Zhenyang Shi
- Employees
- 156
- Beta
- 0.00
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.38) − 1 = — (DCF, example).